Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Iodice R."'
Autor:
Schiavetti I; Department of Health Sciences, University of Genoa, Genova, Italy., Signori A; Department of Health Sciences, University of Genoa, Genova, Italy., Albanese A; Department of Health Sciences, University of Genoa, Genova, Italy., Frau J; Centro Sclerosi Multipla Ospedale Binaghi Cagliari, Azienda Sanitaria Locale (ASL) Cagliari, Cagliari, Italy., Cocco E; Centro Sclerosi Multipla Ospedale Binaghi Cagliari, Azienda Sanitaria Locale (ASL) Cagliari, Cagliari, Italy.; Dipartimento Scienze Mediche e Sanità Pubblica, Università di Cagliari, Cagliari, Italy., Lorefice L; Centro Sclerosi Multipla Ospedale Binaghi Cagliari, Azienda Sanitaria Locale (ASL) Cagliari, Cagliari, Italy., di Lemme S; Unit of Neurology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Neuromed, Pozzilli, Italy., Fantozzi R; Unit of Neurology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Neuromed, Pozzilli, Italy., Centonze D; Unit of Neurology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Neuromed, Pozzilli, Italy.; Department of Systems Medicine, Tor Vergata University, Rome, Italy., Landi D; Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome, Italy., Marfia G; Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome, Italy., Signoriello E; Centro Sclerosi Multipla, II Clinica Neurologica, Università della Campania Luigi Vanvitelli, Naples, Italy., Lus G; Centro Sclerosi Multipla, II Clinica Neurologica, Università della Campania Luigi Vanvitelli, Naples, Italy., Zecca C; Multiple Sclerosis Center, Neurocenter of Southern Switzerland, EOC, Lugano, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland., Gobbi C; Multiple Sclerosis Center, Neurocenter of Southern Switzerland, EOC, Lugano, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland., Iodice R; Clinica Neurologica, DSNRO Università Federico II di Napoli, Napoli, Italy., Malimpensa L; Mediterranean Neurological Institute Neuromed, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Pozzilli, Italy., Cordioli C; Centro Sclerosi Multipla, Azienda Socio Sanitaria Territoriale (ASST) Spedali Civili di Brescia, Montichiari, Italy., Ferraro D; Department of Neurosciences, Ospedale Civile di Baggiovara, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy., Ruscica F; Unità operativa di Neurologia, Fondazione Istituto G.Giglio, Palermo, Italy., Pasquali L; Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Repice A; Department of Neurology 2, Careggi University Hospital, Florence, Italy., Immovilli P; Neurology Unit, Emergency Department, Guglielmo da Saliceto Hospital, Piacenza, Italy., Ferrò MT; Neurological Unit, Cerebrovascular Department, Neuroimmunology, Center for Multiple Sclerosis, ASST Crema, Crema, Italy., Bonavita S; Dipartimento di Scienze Mediche e Chirurgiche Avanzate, Università della Campania Luigi Vanvitelli, Naples, Italy., Di Filippo M; Clinica Neurologica, Dipartimento di Medicina e Chirurgia, Università di Perugia, Perugia, Italy., Abbadessa G; I Division of Neurology, University of Campania 'Luigi Vanvitelli', Naples, Italy., Govone F; Centro Sclerosi Multipla-Neurologia di Mondovì, Cuneo, Italy., Sormani MP; Department of Health Sciences, University of Genoa, Genova, Italy.; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Publikováno v:
European journal of neurology [Eur J Neurol] 2024 Jun; Vol. 31 (6), pp. e16250. Date of Electronic Publication: 2024 Mar 28.
Autor:
Aruta F; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University Federico II of Naples,Via Sergio Pansini, 580131 Naples Italy. Electronic address: fra.aruta@libero.it., Iovino A; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University Federico II of Naples,Via Sergio Pansini, 580131 Naples Italy., Costa C; Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Naples, Italy., Manganelli F; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University Federico II of Naples,Via Sergio Pansini, 580131 Naples Italy., Iodice R; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University Federico II of Naples,Via Sergio Pansini, 580131 Naples Italy.
Publikováno v:
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2020 Jun; Vol. 41, pp. 102023. Date of Electronic Publication: 2020 Feb 28.
Autor:
Sormani M. P., Schiavetti I., Carmisciano L., Inglese M., Laroni A., Lapucci C., Uccelli A., Da Rin G., Serrati C., Gandoglia I., Tassinari T., Perego G., Brichetto G., Gazzola P., Mannironi A., Stromillo M. L., Cordioli C., Landi D., Clerico M., Signoriello E., Frau J., Ferro M. T., Di Sapio A., Pasquali L., Ulivelli M., Marinelli F., Callari G., Iodice R., Liberatore G., Caleri F., Repice A. M., Cordera S., Battaglia M. A., Salvetti M., Franciotta D., Maglione A., Signori A., Iovino A., Nicoletti C. G., Mancinelli C. R., Bezzini D., Carmagnini D., Brogi D., Orazio E. N., Cocco E., Nako E., Assandri E., Baldi F., Ansaldi F., Bovis F., Siciliano G., Cola G., Lus G., Icardi G., bellucci G., Rin G. D., Marfia G. A., Vazzoler G., Trivelli G., Maietta I., Sticchi L., Lorefice L., Ruggiero L., Manzino M., Bragadin M. M., Buscarinu M. C., Gagliardi M., Rilla M. T., Ponzano M., Fronza M., Sette M. D., Scialabba M., Bedognetti M., De Rossi N., De Stefano N., Bigi R., Dubbioso R., Renie R., Fabbri S., Rasia S., Rolla S., Platzgummer S., Carlini V.
Publikováno v:
EBioMedicine, Vol 72, Iss, Pp 103581-(2021)
EBioMedicine
EBioMedicine
Background: In patients with Multiple Sclerosis (pwMS) disease-modifying therapies (DMTs) affects immune response to antigens. Therefore, post-vaccination serological assessments are needed to evaluate the effect of the vaccine on SARS-CoV-2 antibody
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::261101604158c2741aadffad00fb60a7
http://hdl.handle.net/11567/1060214
http://hdl.handle.net/11567/1060214
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Multiple Sclerosis and Related Disorders. 41:102023
Cladribine is an approved drug for the treatment of highly active multiple sclerosis. We report a 28-years-old man with a poor response to previous treatments, elected to treatment with Cladribine. He developed a lichenoid rash two weeks after taking